Atrayee Basu-Mallick, MD, highlights established and emerging biomarker-directed therapies in colorectal cancer.
Atrayee Basu-Mallick, MD
Advertisement
Articles by Atrayee Basu-Mallick, MD
Atrayee Basu-Mallick, MD, discusses the importance of clinical research examining the role of circulating tumor DNA in patients with colorectal cancer.
Atrayee Basu-Mallick, MD, discusses factors to consider when selecting a frontline HER2-directed treatment regimen for patients with colorectal cancer.
Atrayee Basu-Mallick, MD, discusses the role of circulating tumor DNA in patients with colorectal cancer.
Advertisement
Latest Updated Articles
Dr. Basu-Mallick on the Importance of Clinical Research Examining ctDNA in CRCPublished: March 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
5